TY - JOUR
T1 - Impacto psicológico del confinamiento por covid-19 hacia un nuevo constructo clinimétrico ansioso-depresivo en mujeres adultas de azogues
AU - Ramírez-Coronel, Andrés Alexis
AU - Cárdenas-Castillo, Paola Fernanda
AU - Martínez-Suárez, Pedro Carlos
AU - Yambay-Bautista, Xavier Rodrigo
AU - Mesa-Cano, Isabel Cristina
AU - Minchala-Urgilés, Rosa Elvira
AU - Andrade-Molina, Marina Cecilia
AU - Sarmiento-Pesántez, Mercedes Magdalena
AU - González-León, Fanny Mercedes
AU - Pogyo-Morocho, Gloria Luzmila
AU - Cárdenas-Cordero, Adrián Javier
AU - Cordero-Zumba, Nancy Beatriz
AU - Pogyo-Morocho, Marcia Verónica
AU - Faicán-Rocano, Pedro Fernando
AU - Arcos-Coronel, Fernando Emanuel
N1 - Publisher Copyright:
© 2020, Venezuelan Society of Pharmacology and Clinical and Therapeutic Pharmacology. All rights reserved.
PY - 2020
Y1 - 2020
N2 - The main objective was to psychometrically establish the nature of the construct underlying the symptoms of anxiety and depression associated with isolation by COVID-19 in adult women of Azogues. A quantitative, non-experimental, prospective and descriptive-correlational study was carried out with a correlational, comparative and predictive cross-sectional design. A simple random sampling was carried out. The sample consisted of 381 adult women (18 to 65 years old) from the city of Azogues, Ecuador. A sociodemographic survey was administered, as well as the State-Trait Anxiety Inventory (STAI) and the State-Trait Depression Inventory (IDER). A descriptive analysis was performed by means of (percentages, frequencies, central tendency measures), a normality test by means of Shapiro Wilk (W), correlation analysis (r Pearson), mean difference analysis (Student t test for independent samples) and finally a multiple linear regression. The first model for predicting anxiety and depression was statistically significant for age (f= 12.66; p= .0001). Anxiety was not a statistically significant predictor for age (β=-0.04; p= .562). While depression was a statistically significant inverse or negative predictor of age (β=-0.27; p= .002). and for the second model of prediction of anxiety and depression was statistically significant for the days of quarantine (f= 4.61; p= .0001). Anxiety was a negative predictor of quarantine days (β=-0.16; p= .002) and depression a positive predictor of quarantine days (β= 0.25; p= .001).
AB - The main objective was to psychometrically establish the nature of the construct underlying the symptoms of anxiety and depression associated with isolation by COVID-19 in adult women of Azogues. A quantitative, non-experimental, prospective and descriptive-correlational study was carried out with a correlational, comparative and predictive cross-sectional design. A simple random sampling was carried out. The sample consisted of 381 adult women (18 to 65 years old) from the city of Azogues, Ecuador. A sociodemographic survey was administered, as well as the State-Trait Anxiety Inventory (STAI) and the State-Trait Depression Inventory (IDER). A descriptive analysis was performed by means of (percentages, frequencies, central tendency measures), a normality test by means of Shapiro Wilk (W), correlation analysis (r Pearson), mean difference analysis (Student t test for independent samples) and finally a multiple linear regression. The first model for predicting anxiety and depression was statistically significant for age (f= 12.66; p= .0001). Anxiety was not a statistically significant predictor for age (β=-0.04; p= .562). While depression was a statistically significant inverse or negative predictor of age (β=-0.27; p= .002). and for the second model of prediction of anxiety and depression was statistically significant for the days of quarantine (f= 4.61; p= .0001). Anxiety was a negative predictor of quarantine days (β=-0.16; p= .002) and depression a positive predictor of quarantine days (β= 0.25; p= .001).
KW - Anxiety
KW - Confinement
KW - Depression
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85102445365&partnerID=8YFLogxK
U2 - 10.5281/zenodo.4542465
DO - 10.5281/zenodo.4542465
M3 - Artículo
AN - SCOPUS:85102445365
SN - 0798-0264
VL - 39
SP - 923
EP - 934
JO - Archivos Venezolanos de Farmacologia y Terapeutica
JF - Archivos Venezolanos de Farmacologia y Terapeutica
IS - 8
ER -